HIMS is a ticking time bomb

What do people on Reddit think?

🚨 Reddit sentiment: mixed/positive - While there are concerns about a potential stock hit from the semaglutide shortage ending and short positions, there is also confidence in Hims' financial growth, product diversity, and customer satisfaction. Summarized comments: - Hims announced plans to sell a cheaper, generic version of a diabetes drug, liraglutide. - Company's revenue and profit are increasing, with products including semaglutide, sexual health, and hair loss treatments. - Concerns about a short thesis exist, but some still find the financial position reasonable. - There's speculation that the release of generic drugs could double the stock price by spring. - The company has responded multiple times to tirzepatide shortage news, with an expectation that the stock will drop when the semaglutide shortage ends. - Hims' core business is focused on erectile dysfunction and hair treatments, not heavily reliant on semaglutide. - Some users maintain that customers appreciate Hims' services for various needs, predicting success beyond 2025. - A user experienced significant losses when covering a short position. Stock tickers discussed: HIMS